Flow cytometry and cell sorting are inetegral and non-dispensible components of modern biomedical research. These techniques allow for the rapid identification of individual cells within a mixed population based on such properties as cell surface antigen expression, cell cycle status, cell signaling, or fluorescencetagged transgenes. Furthermore, once cell populations are identified they can be isolated into discreet populuations via cell sorting. The University of Colorado Cancer Center Flow Cytometry Core is a state-ofthe- art facility that provides two machines capable of high speed cell sorting based on 7-color or 9-color parameters, respectively. Additionally the core provides three flow analysis machines capable of 4, 5, and 9- color analysis, respectively.The Flow Core also provides the Luminex system for multiplexed bead array analysis. Additionally Flow Core personnel provide a consulting service for analysis and cell sorting strategies. The Flow Core will be used extensively for investigators involved in skin disease: we will be capable of identifying and isolating various skin cell subpopulations, such as keratinocytes and keratinocyte stem cell populations, as well as isolating normal and tumor skin stem cells from tissues or cell cultures for further in vitro and in vivo analysis. Additionally investigators will be able to identify, isolate, and further assess phenotype-specific T cell or other immune cell populations associated with various skin pathologies. ore center support for the Flow Core will insure that investigators of the Skin Disease Research Core Center (SDRC) will have full access to all services provided by the Flow Cytometry and Cell Sorting Core at a discounted rate.
The services of this core component will allow SDRC investigators access to flow analysis of cells in skin disease models, both in vitro and in vivo. Moreover the Flow Cytometry Core will provide the only practical means of isolating rare stem cell populations or immune cell subsets from skin cell preparations or cell cultures. Funding of the Flow Cytometry Core will provide full access to core services at a discounted rate.
|Gaskill, Christa F; Carrier, Erica J; Kropski, Jonathan A et al. (2017) Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction. J Clin Invest 127:2262-2276|
|Miller, Shannon M; Miles, Brodie; Guo, Kejun et al. (2017) Follicular Regulatory T Cells Are Highly Permissive to R5-Tropic HIV-1. J Virol 91:|
|Mukherjee, Nabanita; Lu, Yan; Almeida, Adam et al. (2017) Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells. Oncotarget 8:46801-46817|
|Yang, N; Leung, E L-H; Liu, C et al. (2017) INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma. Oncogene 36:4997-5005|
|Birlea, Stanca A; Costin, Gertrude-E; Roop, Dennis R et al. (2017) Trends in Regenerative Medicine: Repigmentation in Vitiligo Through Melanocyte Stem Cell Mobilization. Med Res Rev 37:907-935|
|Zhai, Z; Liu, W; Kaur, M et al. (2017) NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma. Oncogene 36:3820-3830|
|Reynolds, Susan D; Rios, Cydney; Wesolowska-Andersen, Agata et al. (2016) Airway Progenitor Clone Formation Is Enhanced by Y-27632-Dependent Changes in the Transcriptome. Am J Respir Cell Mol Biol 55:323-36|
|Goldstein, Nathaniel B; Koster, Maranke I; Hoaglin, Laura G et al. (2016) Isolating RNA from precursor and mature melanocytes from human vitiligo and normal skin using laser capture microdissection. Exp Dermatol 25:805-11|
|Morton, J J; Bird, G; Keysar, S B et al. (2016) XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene 35:290-300|
|Du, L; Chen, X; Cao, Y et al. (2016) Overexpression of PIK3CA in murine head and neck epithelium drives tumor invasion and metastasis through PDK1 and enhanced TGF? signaling. Oncogene 35:4641-52|
Showing the most recent 10 out of 54 publications